FIELD: biotechnology, pharmacy. SUBSTANCE: method involves preparing the parent solution of chymopapain, passing unpurified solution through column with affinity chromatography matrix exhibiting specificity to chymopapain active site and backing that is bound by covalent linkage with N-terminal end of chymopapain-inhibitory peptide through the spacer group. C-terminal amino acid of chymopapain-inhibitory peptide is a derivative of phenylalanine, alanine, cyclohexylalanine or leucine that is bound with chymopapain active site more firmly than with PPIV active site. The indicated peptide is bound to chymopapaine molecule active site. Elution is carried out by suitable eluent at pH = 1.2-1.8 followed by separation of ballast proteins, neutralization of eluate and its desalting by dialysis, passing through column with the indicated matrix for affinity chromatography, eluation of chymopapain with suitable eluent, combining active fractions, their dialysis and lyophilic drying. EFFECT: improved method of purification. 4 cl, 10 tbl
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | 2,4-DICHLOROBENZYL ALCOHOL AND AMYLMETHACRESOL AGAINST HIV-INFECTION | 1996 |  | RU2204385C2 | 
							
              
                | GUANIDINE DERIVATIVES, A METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING HYPOGLYCEMIC ACTIVITY | 1992 | 
										Balasabraman'Jan Gopalan[In] | RU2099323C1 | 
							
              
                | PHARMACEUTICAL COMPOSITION CONTAINING (S)-(-)-2-(4-ISOBUTYL- -PHENYL)-PROPIONATE SODIUM, METHOD OF SYNTHESIS OF 2-(4- -ISOBUTYLPHENYL)-PROPIONIC ACID SODIUM SALT ENANTIOMER, (S)-(-)-2-(4-ISOBUTYLPHENYL)-PROPIONATE SODIUM DIHYDRATE | 1992 | 
										Bernard Dzhon ArmitedzhPol Frederik KoDzhon Frensis LampardAlan Smit | RU2145219C1 | 
							
              
                | METHOD OF SYNTHESIS OF AMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 0 |  | SU1826969A3 | 
							
              
                | METHOD OF PRODUCING HETEROCYCLIC DERIVATIVES OF CYCLOBUTYLAMINOMETHAN | 0 | 
										Bernard Dzhon ArmitejdzhDzhon Rozindejl KhauslejDzhejms Edvard DzheffriDevid Norman Dzhonston | SU1274622A3 | 
							
              
                | TETRAHYDROISOQUINOLINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DOPHAMINE RECEPTOR BINDING | 1992 | 
										Ehntonin KozlikBrjus Dzheremi SargentPatrisija Lesli Nidkhehm | RU2122999C1 | 
							
              
                | METHOD OF SYNTHESIS OF PHENYLPROPIONIC ACID | 1993 | 
										Robert KhardiPol' Frederik KoeAdrian KherstKh'Ju Ouehn O'Donnel | RU2133733C1 | 
							
              
                | METHOD OF OBTAINING QUINOLONS | 0 |  | SU1151203A3 | 
							
              
                | 2,3,4,5-TETRAHYDRO-1,4-BENZOTHIAZEPINES, STEREOISOMERS THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION HAVING ANTICONVULSIVE EFFECT | 1993 | 
										Dzhon Rosindehjl KhousliDzhejms Ehdvard DzhefferiKennet Dzhon Nikol'Brjus Dzheremi Sardzhent | RU2115650C1 | 
							
              
                | THERAPEUTIC AGENTS | 1997 |  | RU2207851C2 |